Cardiff Oncology, Inc. (CRDF)

0.97 USDclose 2026-10-15Healthcare
Gurus hold—none of the tracked superinvestors
Net buying (quarter)—latest quarter, superinvestors
Market Cap$75.5M52 Week Range: 0.81 – 3.21
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.LossEPS -0.55
The live quote provider is unreachable; the last known close is shown.

Cardiff Oncology, Inc. (CRDF) is not among the 30 most-held stocks of the tracked superinvestor set. Price 0.97 USD; market cap $75.5M.

Price & valuation

Prev Close—
Open—
Day Range—
52 Week Range0.81 – 3.21
Volume—
Avg Volume (3M)—
Market Cap$75.5MSEC 10-Q, 11/03/2026
BetaVolatility vs the market. Above 1: swings harder than the index.1.252 years, weekly, vs SPY
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.LossSEC 10-Q, 09/30/2026
EPS (TTM)Annual net profit per share.-0.55SEC 10-Q, 09/30/2026
Dividend YieldAnnual dividend over share price.—

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

About

SectorHealthcare
Industry—
Employees—
Website—

Frequently Asked Questions

Which superinvestors own CRDF?

Cardiff Oncology, Inc. (CRDF) is not among the 30 most-held stocks of the tracked superinvestor set.

Is institutional sentiment on CRDF bullish or bearish?

CRDF is not among the 30 most-held stocks of the superinvestor set, so net buyer/seller counts are not computed for it.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.